Instituto Médico Damic S.R.L.
Instituto médico DAMIC es un centro pionero en investigación clínica de la ciudad de Córdoba, Argentina.Select an option
I am a doctor
I am a sponsor
Specializations
Taquicardia supraventricular paroxística
Enfermedad de Crohn
Colitis ulcerosa
Obesidad
Cardiovascular
Diabetes
Our team
Medical staff
Adriana Villarino
Alberto Lorenzatti
Luis Guzmán
Diego Martinez
Felipe Martinez
Gerardo García Bonetto
Raquel Bauducco
Marcela Flores
Jaquelina Erazo
Lorena Fernandez
Veronica Tinnirello
Alexis Cazaux
Angelica Baima
Miriam Rosetti
Esteban Donaire
Candela Garcia Carot
Open studies
Cardiovascular disease
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels - REDEFINE 3 - Novo Nordisk A/SSee more
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Obesity
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels - REDEFINE 3 - Novo Nordisk A/SSee more
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease - TRIUMPH-3 - Eli Lilly and CompanySee more
Cardiac arrhythmia
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation - LIBREXIA-AF - Janssen Research & Development, LLCSee more
Hypercholesterolemia
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer IngelheimSee more
